Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine-assisted therapy experience on clinicians' therapeutic competencies
NCT05468047Phase 1Unknown
- Sponsor
- Integrative Psychiatry Institute
- Start
- Sep 2022
- Primary completion
- Sep 2024
- Modality
- Small Molecules
01
Overview
Phase 1, open-label trial of ketamine, sponsored by Integrative Psychiatry Institute. Primary endpoints: Development of Psychotherapists Common Core Questionnaire at 5 weeks and Counseling Self Estimate Inventory at 5 weeks. Status: unknown.
02
Drugs
ketamine
Beyond the preview
Go deeper on NCT05468047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05468047.